Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Kennedy Krieger Institute

www.kennedykrieger.org

Latest From Kennedy Krieger Institute

Neurotech SA

Neurotech is making use of the angiogenic properties of tumors to eradicate them. Beyond brain tumors, Neurotech is targeting other conditions where angiogenesis is important, for example, ischemic stroke. Neuortech's approach is also suited to a variety of other neurological disorders, including Alzheimer's disease and Parkinson's disease.
BioPharmaceutical
See All
Advertisement
Advertisement
UsernamePublicRestriction

Register